SARS-CoV-2 infects cells via its spike protein binding to its surface receptor on target cells
and results in acute symptoms involving especially the lungs known as COVID-19. However …

In late December 2019, multiple atypical pneumonia cases resulted in severe acute
respiratory syndrome caused by a pathogen identified as a novel coronavirus SARS-CoV-2 …

The Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
has now spread throughout the world. We used computational tools to assess the spike …

It is unclear whether severe acute respiratory syndrome coronavirus 2, which causes
coronavirus disease 2019, can enter the brain. Severe acute respiratory syndrome …

The availability of sensors able to rapidly detect SARS-CoV-2 directly in biological fluids in a
single step would allow performing massive diagnostic testing to track in real time and …

Rapid, mass diagnosis of the coronavirus disease 2019 (COVID-19) is critical to stop the
ongoing infection spread. The two standard screening methods to confirm the severe acute …

A rapid detection test for SARS-CoV-2 is urgently required to monitor virus spread and
containment. Here, we describe a test that uses nanoprobes, which are gold nanoparticles …

The devastating COVID-19 pandemic is caused by the SARS-CoV-2 virus. It primarily affects
the lung and induces acute respiratory distress leading to a decrease in oxygen supply to …

Despite tremendous efforts in the past two years, our understanding of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …

Experimental findings for SARS-CoV-2 related to the glycan biochemistry of coronaviruses
indicate that attachments from spike protein to glycoconjugates on the surfaces of red blood …